S

Sunzen Biotech Bhd
KLSE:SUNZEN

Watchlist Manager
Sunzen Biotech Bhd
KLSE:SUNZEN
Watchlist
Price: 0.315 MYR 1.61% Market Closed
Market Cap: 253.5m MYR
Have any thoughts about
Sunzen Biotech Bhd?
Write Note

Sunzen Biotech Bhd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sunzen Biotech Bhd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Accounts Receivables
myr14.8m
CAGR 3-Years
19%
CAGR 5-Years
-9%
CAGR 10-Years
7%
D
Dswiss Inc
OTC:DQWS
Accounts Receivables
$51k
CAGR 3-Years
-29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Eng Kah Corporation Bhd
KLSE:ENGKAH
Accounts Receivables
myr5m
CAGR 3-Years
-26%
CAGR 5-Years
-17%
CAGR 10-Years
-11%
K
Karex Bhd
KLSE:KAREX
Accounts Receivables
myr123.1m
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
4%
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Accounts Receivables
myr3.1m
CAGR 3-Years
-52%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
No Stocks Found

Sunzen Biotech Bhd
Glance View

Market Cap
253.5m MYR
Industry
Consumer products

Sunzen Biotech Bhd.is an investment holding company, which engages in biotechnology research and development, and the manufacture and marketing of animal feed supplement products. The company is headquartered in Shah Alam, Selangor. The company went IPO on 2008-10-08. Its segments include Manufacturing and trading of animal health products (AH), Trading of crude palm oil products (CPO), Traditional Chinese medicines, herbal foods and beverages, bird's nest (TCM) and Loan financing. The company specializes in animal health and nutrition, manufactures and markets a range of related products for both livestock and companion animals. The company is also involved in the palm oil trading business, which entails the trading of crude palm oil and its derivative products. Its product categories include feed additive, oral pump, functional red palm oil, injectables, water soluble, detergent and disinfection and premix. Its animal health products are offered to domestic and overseas markets in countries, such as China, Korea and the Middle East.

SUNZEN Intrinsic Value
0.222 MYR
Overvaluation 29%
Intrinsic Value
Price
S

See Also

What is Sunzen Biotech Bhd's Accounts Receivables?
Accounts Receivables
14.8m MYR

Based on the financial report for Jun 30, 2024, Sunzen Biotech Bhd's Accounts Receivables amounts to 14.8m MYR.

What is Sunzen Biotech Bhd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
7%

Over the last year, the Accounts Receivables growth was 16%. The average annual Accounts Receivables growth rates for Sunzen Biotech Bhd have been 19% over the past three years , -9% over the past five years , and 7% over the past ten years .

Back to Top